BIOMUNE COMPANY has a total of 33 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are GEOVAX INC, CELL MED RES GMBH and PULIKE BIOLOGICAL ENG INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Brazil | 3 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Mexico | 2 | |
#8 | Peru | 1 | |
#9 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Ford Brianna | 12 |
#2 | Ruehling Roger H | 7 |
#3 | Sawarkar Sharad Devidasrao | 6 |
#4 | Dorsey Kristi Mae | 6 |
#5 | Gully Christopher Patrick | 6 |
#6 | Leonard Joan D | 5 |
#7 | Rosenberger John Knox | 5 |
#8 | Rosenberger Sandra Cloud | 4 |
#9 | Luther Christopher | 3 |
#10 | Jensen Lauren Elizabeth | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021011465A1 | Method for vaccinating avians against reovirus | |
CA3106341A1 | New vaccines against avian reoviruses | |
US2017096644A1 | IBV strains and uses thereof | |
US2015359880A1 | Dual adjuvant vaccine compositions, preparation and uses | |
US2014255447A1 | Production of avian embryo cells | |
WO2012092226A1 | Veterinary vaccine composition against infections caused by salmonella | |
WO2009158618A2 | Avian reoviridae | |
MXPA06010131A | Chicken anemia virus vaccine from cell line. |